Use of Cre-adenovirus and CAR transgenic mice for efficient deletion of genes in post-thymic T cells

Journal of Immunological Methods

Volumn 331, Issue 1-2, 2008, Pages 94-102

  Zha, Yuanyuan ^a   Shah, Ramila ^a   Locke, Frederick ^a   Wong, Austin ^a   Gajewski, Thomas F ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Adenoviral transduction; CAR; Cre; T cells

Indexed keywords

ADENOVIRUS VECTOR; CRE RECOMBINASE; INTERLEUKIN 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENETIC TRANSDUCTION; LYMPHOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; TRANSGENIC MOUSE; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; GENE DELETION; GENETIC ENGINEERING; GENETIC VECTORS; MICE; MICE, TRANSGENIC; PROTEINS; PTEN PHOSPHOHYDROLASE; RECEPTORS, VIRUS; RECOMBINATION, GENETIC; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; MUS; MUS MUSCULUS;

EID: 39149144834     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.11.013     Document Type: Article

References (30)

1. Belteki G., Haigh J., Kabacs N., Haigh K., Sison K., Costantini F., Whitsett J., Quaggin S.E., and Nagy A. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res. 33 (2005) e51
2. Brown I.E., Blank C., Kline J., Kacha A.K., and Gajewski T.F. Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection. J. Immunol. 177 (2006) 4521
3. Buckler J.L., Walsh P.T., Porrett P.M., Choi Y., and Turka L.A. Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J. Immunol. 177 (2006) 4262
4. Cosmi L., Liotta F., Angeli R., Mazzinghi B., Santarlasci V., Manetti R., Lasagni L., Vanini V., Romagnani P., Maggi E., Annunziato F., and Romagnani S. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 103 (2004) 3117
5. de Boer J., Williams A., Skavdis G., Harker N., Coles M., Tolaini M., Norton T., Williams K., Roderick K., Potocnik A.J., and Kioussis D. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33 (2003) 314
6. Di Cristofano A., Kotsi P., Peng Y.F., Cordon-Cardo C., Elkon K.B., and Pandolfi P.P. Impaired Fas response and autoimmunity in Pten+/- mice. Science 285 (1999) 2122
7. Dower N.A., Stang S.L., Bottorff D.A., Ebinu J.O., Dickie P., Ostergaard H.L., and Stone J.C. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat. Immunol. 1 (2000) 317
8. Gajewski T.F., Joyce J., and Fitch F.W. Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma. J. Immunol. 143 (1989) 15
9. Griffin M.D., Hong D.K., Holman P.O., Lee K.M., Whitters M.J., O'Herrin S.M., Fallarino F., Collins M., Segal D.M., Gajewski T.F., Kranz D.M., and Bluestone J.A. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152). J. Immunol. 164 (2000) 4433
10. Gu H., Marth J.D., Orban P.C., Mossmann H., and Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265 (1994) 103
11. Hagenbeek T.J., Naspetti M., Malergue F., Garcon F., Nunes J.A., Cleutjens K.B., Trapman J., Krimpenfort P., and Spits H. The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J. Exp. Med. 200 (2004) 883
12. Hamilton D.L., and Abremski K. Site-specific recombination by the bacteriophage P1 lox-Cre system. Cre-mediated synapsis of two lox sites. J. Mol. Biol. 178 (1984) 481
13. Jo D., Nashabi A., Doxsee C., Lin Q., Unutmaz D., Chen J., and Ruley H.E. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat. Biotechnol. 19 (2001) 929
14. Logan M., Martin J.F., Nagy A., Lobe C., Olson E.N., and Tabin C.J. Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 33 (2002) 77
15. Marks R.E., Ho A.W., Rivas F., Marshall E., Janardhan S., and Gajewski T.F. Differential Ras signaling via the antigen receptor and IL-2 receptor in primary T lymphocytes. Biochem. Biophys. Res. Commun. 312 (2003) 691
16. Munitic I., Williams J.A., Yang Y., Dong B., Lucas P.J., El Kassar N., Gress R.E., and Ashwell J.D. Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis. Blood 104 (2004) 4165
17. Nagy A. Cre recombinase: the universal reagent for genome tailoring. Genesis 26 (2000) 99
18. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., Park L.S., Ziegler S.F., Williams D.E., Ware C.B., Meyer J.D., and Davison B.L. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180 (1994) 1955
19. Purton J.F., Sprent J., and Surh C.D. Staying alive - naive CD4(+) T cell homeostasis. Eur. J. Immunol. 37 (2007) 2367
20. Rivas F.V., O'Herrin S., and Gajewski T.F. CD28 is not required for c-Jun N-terminal kinase activation in T cells. J. Immunol. 167 (2001) 3123
21. Rowland B., Purkayastha A., Monserrat C., Casart Y., Takiff H., and McDonough K.A. Fluorescence-based detection of lacZ reporter gene expression in intact and viable bacteria including Mycobacterium species. FEMS Microbiol. Lett. 179 (1999) 317
22. Sakai A., Thieblemont C., Wellmann A., Jaffe E.S., and Raffeld M. PTEN gene alterations in lymphoid neoplasms. Blood 92 (1998) 3410
23. Seki Y., Yang J., Okamoto M., Tanaka S., Goitsuka R., Farrar M.A., and Kubo M. IL-7/STAT5 cytokine signaling pathway is essential but insufficient for maintenance of naive CD4 T cell survival in peripheral lymphoid organs. J. Immunol. 178 (2007) 262
24. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21 (1999) 70
25. Suzuki A., Yamaguchi M.T., Ohteki T., Sasaki T., Kaisho T., Kimura Y., Yoshida R., Wakeham A., Higuchi T., Fukumoto M., Tsubata T., Ohashi P.S., Koyasu S., Penninger J.M., Nakano T., and Mak T.W. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14 (2001) 523
26. Tripathi P., Madan R., Chougnet C., Divanovic S., Ma X., Wahl L.M., Gajewski T., Karp C.L., and Hildeman D.A. An adenoviral vector for probing promoter activity in primary immune cells. J. Immunol. Methods 311 (2006) 19
27. Wan Y.Y., Leon R.P., Marks R., Cham C.M., Schaack J., Gajewski T.F., and DeGregori J. Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 13784
28. Wang X., Zeng W., Murakawa M., Freeman M.W., and Seed B. Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression. J. Virol. 74 (2000) 11296
29. Wilson T.J., Cowdery H.E., Xu D., Kola I., and Hertzog P.J. A human CD2 minigene directs CRE-mediated recombination in T cells in vivo. Genesis 33 (2002) 181
30. Zambrowicz B.P., Imamoto A., Fiering S., Herzenberg L.A., Kerr W.G., and Soriano P. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3789